Kyoto Fusioneering is developing two next-generation breeder-blanket structural materials. One is a family of vanadium alloys ...

Academic scientists and pharmaceutical companies alike are embracing artificial intelligence, even as questions linger about ...

There are only three antivirals authorized by the US Food and Drug Administration (FDA) for treating COVID-19. If the ...

The Department of Energy wants to terminate 321 funding awards mostly related to clean energy and grid stabilization ...

The team genetically engineered fruit flies to make naked mole rat cGAS and found that they lived 70 days—10 days longer than ...

Neuroscience start-up Bexorg has raised a $42.5 million series A funding round in its mission to use donated brains and ...

Following Phase 3 trials, the drug candidate manufacturer can apply for a New Drug Application (NDA) from the FDA. The FDA ...

Proponents of the use of synthetic biology say it could bring some species back from the brink of extinction and help fight ...

Building on work by Hiroyuki Osada’s group, which reported that the antibiotic hygromycin B induced fungal metabolites in one ...

Susumu Kitagawa, Richard Robson, and Omar M. Yaghi have won the chemistry Nobel Prize “for the development of metal–organic ...

Takeda Pharmaceuticals and Nabla Bio, a start-up focused on designing de novo proteins with artificial intelligence, have ...